Your browser doesn't support javascript.
loading
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence.
Moneer, Osman; Brown, Beatrice L; Avorn, Jerry; Darrow, Jonathan J; Mitra-Majumdar, Mayookha; Joyce, Krysten W; Ross, Murray; Pham, Catherine; Kesselheim, Aaron S.
Afiliação
  • Moneer O; Yale School of Medicine, New Haven, CT, USA.
  • Brown BL; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Avorn J; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Darrow JJ; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Mitra-Majumdar M; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Joyce KW; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Ross M; Kaiser Permanente Institute for Health Policy, Oakland, CA, USA.
  • Pham C; Kaiser Permanente Institute for Health Policy, Oakland, CA, USA.
  • Kesselheim AS; Kaiser Permanente National Pharmacy, Downey, CA, USA.
Drug Saf ; 45(4): 305-318, 2022 04.
Article em En | MEDLINE | ID: mdl-35182362

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vigilância de Produtos Comercializados / Aprovação de Drogas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vigilância de Produtos Comercializados / Aprovação de Drogas Idioma: En Ano de publicação: 2022 Tipo de documento: Article